Insights

Partner Expansion Partillion’s distribution partnership with Sony Biotechnology offers a potential route to broader customer reach. Business development teams could explore complementary distribution, co marketing, or integration opportunities that extend access to Nanovial based functional cell analysis.

Assay Development The 2025 Developer Kits give customers validated capture antibodies and standardized reagents for building custom assays and workflows. This creates an opportunity to engage biotech and pharmaceutical teams seeking faster assay setup, workflow customization, or technical support.

Platform Adoption Partillion trains researchers to run Nanovial assays on two commercial cell sorting platforms and has promoted the technology at cytometry events. Sales teams can target labs already using cell sorting and position training, implementation, and platform-compatible workflows as adoption support.

Research Credibility Nanovial technology has appeared in leading scientific journals and earned multiple awards, including the 2025 CYTO Innovation & Technology Showcase Award. This credibility can support outreach to organizations evaluating functional cell analysis for secretion, signaling, viability, and cell interaction studies.

Growth Potential With 11 to 50 employees, estimated revenue of $1 million to $10 million, and $6.1 million in funding, Partillion is a relatively small company building a specialized platform. Potential sales opportunities include scalable services and tools that support customer acquisition, laboratory operations, analytics, or commercial growth.

Similar companies to Partillion Bioscience

Partillion Bioscience Tech Stack

Partillion Bioscience uses 8 technology products and services including HubSpot Analytics, Squarespace, Squarespace Commerce, and more. Explore Partillion Bioscience's tech stack below.

Media & News

Partillion Bioscience's Email Address Formats

Partillion Bioscience uses at least 2 email formats:
Partillion Bioscience Email FormatsExamplePercentage
First@partillion.comJohn@partillion.com
97%
First.Last@partillion.comJohn.Doe@partillion.com
3%

Frequently Asked Questions

What is Partillion Bioscience's official website and social media links?

Minus sign iconPlus sign icon
Partillion Bioscience's official website is partillion.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Partillion Bioscience generate?

Minus sign iconPlus sign icon
As of October 2026, Partillion Bioscience's annual revenue is estimated to be $1M - $10M.

What is Partillion Bioscience's SIC code and NAICS code?

Minus sign iconPlus sign icon
Partillion Bioscience's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Partillion Bioscience have currently?

Minus sign iconPlus sign icon
As of October 2026, Partillion Bioscience has approximately 15 employees across 2 continents, including North America and Oceania. Key team members include Global Business Development Director: F. S. Explore Partillion Bioscience's employee directory with LeadIQ.

What industry does Partillion Bioscience belong to?

Minus sign iconPlus sign icon
Partillion Bioscience operates in the Biotechnology Research industry.

What technology does Partillion Bioscience use?

Minus sign iconPlus sign icon
Partillion Bioscience's tech stack includes HubSpot Analytics, Squarespace, Squarespace Commerce, Stimulus, jQuery, AfterPay, Bokeh and Sitelinks Search Box.

What is Partillion Bioscience's email format?

Minus sign iconPlus sign icon
Partillion Bioscience's email format typically follows the pattern of First@partillion.com. Find more Partillion Bioscience email formats with LeadIQ.

How much funding has Partillion Bioscience raised to date?

Minus sign iconPlus sign icon
As of October 2026, Partillion Bioscience has raised $6.1M in funding. The last funding round occurred on Sep 26, 2023 for $5M.

When was Partillion Bioscience founded?

Minus sign iconPlus sign icon
Partillion Bioscience was founded in 2020.
Partillion Bioscience logo

Partillion Bioscience

Biotechnology ResearchCalifornia, United States11-50 Employees

Partillion Bioscience is a Los Angeles-based biotechnology research company focused on advancing single-cell analysis. Its nanovial platform enables rapid compartmentalization and analysis of millions of individual cells to probe functions such as secreted proteins. The technology has been validated in peer-reviewed journals and has earned industry recognition, including the 2020 SLAS Innovation Award.

Positioned in the biotechnology research tools sector, Partillion serves researchers seeking scalable, high-throughput single-cell assays. The company has demonstrated ongoing engagement with the scientific community, including showcasing its nanovials at CYTO 2026.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2020
Employees
11-50

Section iconFunding & Financials

  • $6.1M

    Partillion Bioscience has raised a total of $6.1M of funding over 5 rounds. Their latest funding round was raised on Sep 26, 2023 in the amount of $5M as a Seed.

  • $1M - $10M

    Partillion Bioscience's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.